First human tests: drug company checks safety of new compound
NCT ID NCT06984926
Summary
This early-stage study aimed to check the safety and how the body processes a new compound called BI 3810477. It involved 47 healthy adult volunteers who received either the compound or a placebo. The main goal was to see what side effects might occur and to measure how much of the drug stays in the blood over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SGS Life Science Services - Clinical Research
Edegem, 2650, Belgium
Conditions
Explore the condition pages connected to this study.